Polynovo Ltd (MFJ F) stock market data APIs
€0.6724
0(0%)
as of January 16, 2026
Try our APIs with
free plan!
Polynovo Ltd Financial Data Overview
Price chart is built with
Anychart
PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to treat type 1 diabetes; NovoSorb MTX for single stage grafting in burns, chronic, and surgical wounds; and plastics and reconstructive device products. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Prev. Close
0.6724
Open
0.6724
High
0.6724
Low
0.6724
52 wk Range
0.48-1.34
Market Cap
489 M
P/E Ratio
67
Shares Outstanding
691 M
Revenue
129 M
EPS
0.01
Beta
1.621
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Polynovo Ltd data using free add-ons & libraries
Get Polynovo Ltd Fundamental Data
Polynovo Ltd Fundamental data includes:
- Net Revenue: 129 M
- EBITDA: 10 005 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-08-25
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Polynovo Ltd News
New
Is PolyNovo Limited (ASX:PNV) Potentially Undervalued?
While PolyNovo Limited (ASX:PNV) might not have the largest market cap around , it saw a significant share price rise of 55% in the past couple of months on the ASX. The recent rally in share prices h...
PolyNovo Limited (ASX:PNV) Shares Could Be 48% Below Their Intrinsic Value Estimate
Key Insights Using the 2 Stage Free Cash Flow to Equity, PolyNovo fair value estimate is AU$2.95 Current share price of AU$1.55 suggests PolyNovo is potentially 48% undervalued The AU$1.81 analyst pr...
PolyNovo (ASX:PNV) shareholders have earned a 21% CAGR over the last five years
When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose your money. But when you pick a company that is really flourishing, you can make mor...
PolyNovo Limited (ASX:PNV) Is About To Turn The Corner
With the business potentially at an important milestone, we thought we'd take a closer look at PolyNovo Limited's (ASX:PNV) future prospects. PolyNovo Limited develops medical devices in the United St...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
